Assessing mental illnesses through digital phenotyping

Digital phenotyping approaches that collect and analyze smartphone-user data on locations, activities, and even feelings – combined with machine learning to recognize patterns and make predictions from the data – have emerged as promising tools for monitoring patients with psychosis spectrum illnesses, according to a new report.

Photo

John Tourous, MD, MBI, of Harvard Medical School and colleagues reviewed available evidence on digital phenotyping and machine learning to improve care for people living with schizophrenia, bipolar disorder, and related illnesses. “Digital phenotyping provides a much-needed bridge between patients’ symptomatology and the behaviors that can be used to assess and monitor psychiatric disorders,” the researchers write.

“Digital phenotyping is the use of data from smartphones and wearables collected in situ for capturing a digital expression of human behaviors,” according to the authors. Psychiatry researchers think that collecting and analyzing this kind of behavioral information might be useful in understanding how patients with severe mental illness are functioning in everyday life outside of the clinic or lab – in particular, to assess symptoms and predict clinical relapses.

Dr. Tourous and colleagues identified 51 studies of digital phenotyping in patients with schizophrenia or bipolar disorder. The review focused on studies using “passively” collected data – for example, accelerometer readings (step counters) and GPS signals. Other digital phenotyping approaches use “actively” collected data – for example, surveys to ask patients to report their mood.

The studies varied in terms of the digital phenotyping features used, data handling, analytical techniques, algorithms tested, and outcome measures reported. Nearly all studies included patients with bipolar disorder or schizophrenia. The studies included an average of 31 participants and monitored them for about four months.

Most studies used passive data collected by accelerometers and GPS; other measures included voice call and text message logs. The studies used a wide range of different apps, as well as different clinical tools/questionnaires for assessing patients' mental health status.

The studies presented higher variability in reporting of basic data such as smartphone model and operating system, patient age and race/ethnicity, and whether patients had received training in use of the technology. The authors make suggestions for a standardized reporting format that would improve the comparability of future studies.

Sixteen of the studies used machine learning-based approaches to analyze the passively collected data. As Dr. Tourous and coauthors note, the studies used various different algorithms, and for different purposes. The most commonly used algorithm type was "random forests," which work by combining many small, weak decisions to make a single strong prediction. For example, one study used passively tracked behavioral data to predict mental health scores in patients with schizophrenia.

Other studies used machine learning approaches such as support vector machine/support vector regression or neural nets. These algorithms work in different ways to use behavioral data—where patients are going, whether they're returning calls, even their tone of voice—to assess patients' current mental health status, predict their risk of relapse, and so forth.

"Digital phenotyping provides a much-needed bridge between patients' symptomatology and the behaviors that can be used to assess and monitor psychotic disorders," Dr. Tourous and colleagues write. They call for larger studies with higher-quality data—along with "expanded efforts to apply machine learning to passive digital phenotyping data in early diagnosis and treatment of psychosis, including in clinical high risk and early-course psychosis patients." 

The report was published in Harvard Review of Psychiatry.

Subscribe to our newsletter

Related articles

AI signals a possible disease resurgence

AI signals a possible disease resurgence

Scientists have used machine learning to predict the reemergence of existing infectious diseases.

Gamification: Intervention app may improve mental health

Gamification: Intervention app may improve mental health

A new randomized control trial has found that turning mobile mental health intervention into a smartphone game can potentially improve well-being.

AI algorithm to help manage diabetes

AI algorithm to help manage diabetes

Researchers, using artificial intelligence and automated monitoring, have designed a method to help people with type 1 diabetes better manage their glucose levels.

App monitors COVID-19 symptoms and mental health needs

App monitors COVID-19 symptoms and mental health needs

A new app that helps patients in self-isolation monitor for symptoms of COVID-19 and identify their mental health needs has been developed.

Wearable helps to manage mental health

Wearable helps to manage mental health

Researchers are working to develop evidence-based services that will help manage students’ mental health.

mhealth: an app to screen for early signs of dementia

mhealth: an app to screen for early signs of dementia

Dementia screening could be as easy as using a smartphone app that listens to elderly people speak.

Video game to treat children with ADHD

Video game to treat children with ADHD

Researchers have developed advanced brain-computer interface technology that harnesses machine learning to personalise brain-training for children with ADHD.

Digital phenotyping helps to treat mental illness

Digital phenotyping helps to treat mental illness

Research shows that digital phenotyping can provide valuable information to mental health professionals about mental illness symptom severity and relapse.

Manipulating brain cells using the smartphone

Manipulating brain cells using the smartphone

A team of scientists have invented a device that can control neural circuits using a tiny brain implant controlled by a smartphone.

Popular articles